These Maryland Companies are G
oing on a Biohealth Trade Mission to the U.K.
February 20, 2019
The Maryland Department of Commerce is taking several companies on a
This Biohealth Trade Mission will provide Maryland companies with an exclusive opportunity to meet with potential investors, partners or customers and start discussions with economic development agencies in the vibrant biotechnology cluster in the U.K. One-to-one meetings with relevant companies and tours to the technology hubs in the Midlands will be organized prior to the trip, as well as other opportunities to experience to the Life Science sector in the region.
“The goal is for them to expand their market,” says Ernesto Chanona, Ph.D., Manager, Business and Innovation Development Office of BioHealth & Life Sciences. “They may collaborate, sell or buy from U.K. business; depending on what the Maryland companies are seeking. In general, they are there to enter the UK market and foster relationships with companies there.”
This Mission will also provide the Maryland Department of Commerce an opportunity to continue fostering relationships with UK economic development agencies to attract companies to Maryland who want to enter the US market. Maryland has a recent history of success to build on with
As part of this trade mission, a “Meet the Buyer” event has been organized by The Midlands Engine, an economic development coalition of Councils, Combined Authorities, Local Enterprise Partnerships (LEP), Universities and businesses across the Midlands region of Britan.
The Midlands Engine is at the cutting-edge of the UK life sciences sector and home to over 1000 life science companies. Working in close partnership with the Department for International Trade (DIT) in the US, we have already helped many UK delegations generate strong connections and reinforce trade commitments.
This ‘Meet the Buyer’ event is a fantastic opportunity for Maryland companies to meet face-to-face with interested buyers from the Midlands region. It’s also an opportunity to showcase the state of Maryland and the Biohealth Capital region as one of the US’s largest innovative
Galen Robotics, Inc: Surgical robotics for otolaryngology and microsurgery.
AQUAS, Inc: Product for tracking and documenting bioethics.
Biotech Diagnostics: Distributor of simple and rapid point-of-care tests to detect antigens or antibodies associated with infectious and parasitic diseases of animals.
Person Clinic: An adaptable eHealth technology solution designed to empower patients and provide a virtual environment backed by science. PerSoN Clinic fills the communication gap between patients, doctors, caregivers and researchers.
Total Child Health, Inc: Development and distribution of a web-based platform called CHADIS (Comprehensive Health and Decision Information System). TCH has been a recipient of thirteen NIH and CDC Small Business Innovation Research awards.
StemCiTerra, LLC: Develops stem cell-based medical treatment that makes tumours more sensitive to other therapies.
Longeviti Neuro Solutions: Neuro innovation company creating a platform of novel medical devices.
ClickMedix: ClickMedix is a global mobile health (mHealth) social enterprise founded by faculty and students from Massachusetts Institute of Technology (MIT) and Carnegie Mellon University to increase capacity of physicians and health organizations to serve more patients.
Integrated Pharma Services: Integrated Pharma Services (IPS) provide services in development and testing of novel therapeutics and diagnostics. Antimicrobial and Anti-Biofilm Efficacy Testing, Custom designed experiments and Consulting services.
Mdlogix: MlLogix combines medical science and information technology to create systems that inspire and guide sustainable change and to make it easier to improve outcomes and address our most pressing public health concerns.
Multisensor Diagnostics: Multisensor Dx is a technology and digital health company reimagining today’s standards for clinical trials, chronic care management, and health monitoring.
For more information on this trade mission, contact Jessica Reynolds at email@example.com
Latest posts by Chris Frew (see all)
- D&D Pharmatech Raises $51M in Series C Financing to Advance Phase 2 Clinical Trials for Neurodegenerative, Fibrotic, and Metabolic Diseases - October 19, 2021
- RoosterBio Names Life Science Industry Leader, Timothy M. Kelly, Ph.D., as New Chief Executive Officer - October 5, 2021
- Adaptive Phage Therapeutics Awarded Additional $8 Million from U.S. Department of Defense for Clinical Advancement of Phage to Address Unmet Needs in Infectious Diseases - September 30, 2021
- Cartesian Therapeutics to double footprint, headcount in Gaithersburg - September 30, 2021
- D&D Pharmatech Announces Agreement with Salubris Pharmaceuticals for Licensing and Development of DD01 in China | Business Wire - September 28, 2021